Beta-1 Adrenergic Inhibition to Reduce Cardiac Injury and Inflammation After Subarachnoid Hemorrhage (BADCATS)

计划入组 20 人 · 首次发布于 2024 年 8 月 23 日

Association Between Genetic Polymorphism of Beta-adrenergic Receptor and Effects of Bisoprolol in Korean Heart Failure Patients.

计划入组 100 人 · 首次发布于 2010 年 4 月 15 日

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

首次发布于 2013 年 2 月 26 日

beta-2 adrenergic receptor antagonist (melanoma)

GB-6249-192

Bisoprolol(Ziac)

C₁₈H₃₁NO₄ · Rx

Beta Bionics

Beta Innov

France

NHI-1

United States

FDA Approves AOP Health's Rapiblyk (Landiolol) for Supraventricular Tachycardia in Critical Care

Eagle Pharmaceuticals Submits NDA for Landiolol, Ultra-Short-Acting Beta Blocker for Critical Care Tachycardia

FDA Approves Rapiblyk (landiolol) for Supraventricular Tachycardia